Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection
- 337 Downloads
To enhance the effect of anti-influenza-virus agent treatment, the effect of combined administration of oseltamivir phosphate and hochu-ekki-to (Japanese traditional herbal medicine, HET) on early viral clearance was examined. Senescence-accelerated mice were given HET in drinking water for 2 weeks, followed by intranasal infection with influenza A virus strain PR8. After 4 hours of infection, oseltamivir was administered orally for 5 days. The viral loads in the lungs of the group receiving combined treatment were dramatically lower when compared with the viral loads in the lungs of the group receiving oseltamivir alone. HET significantly increased the induction of IL-1β and TNF-α in the lungs of PR8-infected mice and stimulated alveolar macrophage phagocytosis. From these results, we conclude that these functions may be responsible the increased effect on viral load reduction. Here, we show that the combined administration of oseltamivir and HET is very useful for influenza treatment in senescence-accelerated mice.
This work was supported by JSPS KAKENHI Grant Number 19590697 and Japan Kampo Medicines Manufacturers Association.
Conflict of interest
The authors declare that they have no conflicts of interest.
- 8.Yong E (2012) Influenza: Five questions on H5N1 Nature 486:456–458Google Scholar
- 16.Kashiwagi S, Yoshida S, Yamaguchi F et al (2012) Clinical efficacy of long-acting neuraminidase inhibitor laninamivir octanoate hydrate in postmarketing surveillance. J Infect Chemother [Epub ahead of print]Google Scholar
- 17.Ison MG, Hui DS, Alexander WJ et al (2012) A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults. Antivir Ther [Epub ahead of print]Google Scholar
- 19.CDC HEALTH ADVISORY (2006) CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 2005–06 influenza season. CDCHAN-00240-2006-01-14-ADV-NGoogle Scholar
- 22.Järhult JD (2012) Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans—a review. Infect Ecol Epidemiol 2:18385Google Scholar
- 31.Mehta T, McGrath E, Alangaden GJ et al (2010) Detection of oseltamivir resistance during treatment of 2009 H1N1influenza virus infection in immunocompromised patients: utility of cycle threshold values of qualitative real-time reverse transcriptase PCR. J Clin Microbiol 48(11):4326–4328PubMedCentralPubMedCrossRefGoogle Scholar
- 33.Kataoka T, Akagawa KS, Tokunaga T, Nagao S (1989) Activation of macrophages with Hochu-ekiito. Jpn J Cancer Chemother 16:1490–1493Google Scholar
- 36.Kiyohara H, Nonaka K, Yamada H et al (2011) Polysaccharide-containing macromolecules in a kampo (traditional Japanese herbal) medicine, hochuekkito: dual active ingredients for modulation of immune functions on intestinal peyer’s patches and epithelial cells. Evid Based Complement Alternat Med 2011:492691PubMedCentralPubMedCrossRefGoogle Scholar